Search VSBC
VITASPRING BIOMEDICAL CO. LTD.
OTC · CIK 1697884
Last close0.01
Daily change+0.00 (0.00%)
10 Years gain-97.36%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
VSBC · STANDARD
SIC 8731 · Services-Commercial Physical & Biological Research · Fiscal year end 0131
Fundamental
22.2Momentum
n/aAcceleration
n/aConfidence
63.0Annual Revenue12
Quarterly Revenue33
Annual CFO12
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality12.5 / 25
Capital Efficiency0.0 / 20
Balance Sheet0.0 / 15
Shareholder Economics8.6 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Key Metrics
Revenue Growth TTMn/aINSUFFICIENT_HISTORY
Revenue CAGR 3Yn/aINSUFFICIENT_HISTORY
Gross Marginn/aMISSING
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y0%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Jan 31, 2026 | $0.00 | $0.00 | -$385,411.00 | -$2,688.00 | n/a | n/a | n/a | n/a | n/a | 207.03M |
| 2026 FY Jan 31, 2025 | $0.00 | $0.00 | -$679,914.00 | -$14,675.00 | n/a | n/a | n/a | n/a | n/a | 207.03M |
| 2025 FY Jan 31, 2024 | $0.00 | n/a | -$1.12M | -$34,920.00 | n/a | n/a | n/a | n/a | n/a | 207.03M |
| 2024 FY Jan 31, 2023 | $0.00 | -$3.33M | -$4.18M | -$77,556.00 | n/a | n/a | n/a | n/a | n/a | 206.52M |
| 2023 FY Jan 31, 2022 | $5.61M | $2.07M | $1.13M | -$269,631.00 | -$342,628.00 | 36.84% | 20.07% | -6.1% | 119.58% | 205.98M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $0.00 | sum latest 4 fiscal quarters Revenue | OK | 0001640334-26-001572, 0001640334-26-001077 |
| Revenue Growth TTM | n/a | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | INSUFFICIENT_HISTORY | 0001640334-26-001572, 0001640334-26-001077 |
| Revenue CAGR 3Y | n/a | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001640334-26-001082 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001640334-26-001082 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001640334-26-001082 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001640334-26-001572, 0001640334-26-001077 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001640334-26-001572 |
| Current Ratio | 0.01x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $0.00 | Revenue / Diluted Shares | OK | 0001640334-26-001572, 0001640334-26-001077 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001640334-26-001082 |
| Diluted EPS TTM | n/a | Net income TTM / Diluted shares | NOT_MEANINGFUL | 0001640334-26-001572 |
| Gross Margin Delta 1Y | n/a | GrossMargin_current - GrossMargin_prior_year | INSUFFICIENT_HISTORY | derived |